MTOR and cancer: A study involving prostate cancer cell lines discovered that compounds aimed at the mTOR pathway were able to inhibit cancer cells in both 2D and 3D cultures, whereas those targeting the AKT pathway showed reduced effectiveness in 2D cultures [54].